Articles by Disease (Neurodegenerative Disorders)

Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview

Journal: Current Pharmaceutical Design
Volume: 21
Page: 317-331
Author(s): P.R.A. Heckman, C. Wouters and J. Prickaerts

Phosphodiesterase-4 Modulation as a Potential Therapeutic for Cognitive Loss in Pathological and Non-Pathological Aging: Possibilities and Pitfalls

Journal: Current Pharmaceutical Design
Volume: 21
Page: 291-302
Author(s): Rolf T. Hansen III and Han-Ting Zhang

Phosphodiesterase: An Interface Connecting Cognitive Deficits to Neuropsychiatric and Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 21
Page: 303-316
Author(s): Zhen-Zhen Wang, Yi Zhang, Han-Ting Zhang and Yun-Feng Li

Editorial (Thematic Issue: Targeting Phosphodiesterases (PDEs) for Treatment of CNS Diseases)

Journal: Current Pharmaceutical Design
Volume: 21
Page: 271-273
Author(s): Han-Ting Zhang

The Roles of Phosphodiesterase 2 in the Central Nervous and Peripheral Systems

Journal: Current Pharmaceutical Design
Volume: 21
Page: 274-290
Author(s): Chong Zhang, Yingcong Yu, Lina Ruan, Chuang Wang, Jianchun Pan, Jonathan Klabnik, Lindsay Lueptow, Han-Ting Zhang, James M. O’Donnell and Ying Xu

In Vitro Effects of Arylhydrocoumarin on Free Radicals and Oxidative Stress in Erythrocytes and Saccharomyces cerevisiae

Journal: Current Pharmaceutical Biotechnology
Volume: 15
Page: 1069-1082
Author(s): Rizangela L.M. de Freitas, George L. da Silva Oliveira, Rivelilson M. de Freitas, André L.B.S. Barreiros, Juceni P. David, Clayton Q. Alves, Charleston R. Pinto and Jorge M. David

Articles by Disease (Neurodegenerative Disorders)

Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview

Phosphodiesterase-4 Modulation as a Potential Therapeutic for Cognitive Loss in Pathological and Non-Pathological Aging: Possibilities and Pitfalls

Phosphodiesterase: An Interface Connecting Cognitive Deficits to Neuropsychiatric and Neurodegenerative Diseases

Editorial (Thematic Issue: Targeting Phosphodiesterases (PDEs) for Treatment of CNS Diseases)

The Roles of Phosphodiesterase 2 in the Central Nervous and Peripheral Systems

In Vitro Effects of Arylhydrocoumarin on Free Radicals and Oxidative Stress in Erythrocytes and Saccharomyces cerevisiae

Oridonin, a Promising Antitumor Natural Product in the Chemotherapy of Hematological Malignancies

Involvement of Trace Elements in the Pathogenesis of Prion Diseases

Physiological Functions of Presenilins; Beyond γ-Secretase

The Implications of Sortilin/Vps10p Domain Receptors in Neurological and Human Diseases